2024 Q2 Form 10-Q Financial Statement
#000088559024000019 Filed on May 02, 2024
Income Statement
| Concept | 2024 Q2 | 2024 Q1 |
|---|---|---|
| Revenue | $2.403B | $2.153B |
| YoY Change | 10.89% | 10.75% |
| Cost Of Revenue | $719.0M | $640.0M |
| YoY Change | 10.79% | 9.97% |
| Gross Profit | $1.684B | $1.513B |
| YoY Change | 10.94% | 11.09% |
| Gross Profit Margin | 70.08% | 70.27% |
| Selling, General & Admin | $832.0M | $794.0M |
| YoY Change | 17.02% | 9.52% |
| % of Gross Profit | 49.41% | 52.48% |
| Research & Development | $156.0M | $151.0M |
| YoY Change | 0.0% | 5.59% |
| % of Gross Profit | 9.26% | 9.98% |
| Depreciation & Amortization | $318.0M | $320.0M |
| YoY Change | 0.95% | 0.31% |
| % of Gross Profit | 18.88% | 21.15% |
| Operating Expenses | $988.0M | $945.0M |
| YoY Change | 13.96% | 8.87% |
| Operating Profit | $389.0M | $281.0M |
| YoY Change | -5.58% | 60.57% |
| Interest Expense | -$353.0M | -$361.0M |
| YoY Change | 6.01% | 16.08% |
| % of Operating Profit | -90.75% | -128.47% |
| Other Income/Expense, Net | -$20.00M | $0.00 |
| YoY Change | -124.1% | -100.0% |
| Pretax Income | $48.00M | -$69.00M |
| YoY Change | -39.24% | -49.26% |
| Income Tax | $49.00M | $8.000M |
| % Of Pretax Income | 102.08% | |
| Net Earnings | $10.00M | -$64.00M |
| YoY Change | -61.54% | -68.16% |
| Net Earnings / Revenue | 0.42% | -2.97% |
| Basic Earnings Per Share | $0.03 | -$0.17 |
| Diluted Earnings Per Share | $0.03 | -$0.17 |
| COMMON SHARES | ||
| Basic Shares Outstanding | 366.8M shares | 365.4M shares |
| Diluted Shares Outstanding | 370.2M shares | 366.8M shares |
Balance Sheet
| Concept | 2024 Q2 | 2024 Q1 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $595.0M | $733.0M |
| YoY Change | 2.76% | 41.51% |
| Cash & Equivalents | $595.0M | $733.0M |
| Short-Term Investments | ||
| Other Short-Term Assets | $902.0M | $979.0M |
| YoY Change | 0.33% | 21.01% |
| Inventory | $1.612B | $1.636B |
| Prepaid Expenses | ||
| Receivables | $2.102B | $2.048B |
| Other Receivables | $0.00 | $0.00 |
| Total Short-Term Assets | $5.211B | $5.396B |
| YoY Change | 16.81% | 27.35% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $1.738B | $1.713B |
| YoY Change | 8.69% | 7.33% |
| Goodwill | $11.13B | $11.16B |
| YoY Change | -4.31% | -3.62% |
| Intangibles | $5.903B | $6.183B |
| YoY Change | 11.4% | 11.37% |
| Long-Term Investments | ||
| YoY Change | ||
| Other Assets | $329.0M | $312.0M |
| YoY Change | 1.23% | -1.89% |
| Total Long-Term Assets | $21.28B | $21.52B |
| YoY Change | 1.15% | 1.46% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $5.211B | $5.396B |
| Total Long-Term Assets | $21.28B | $21.52B |
| Total Assets | $26.50B | $26.91B |
| YoY Change | 3.89% | 5.77% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $579.0M | $642.0M |
| YoY Change | 12.43% | 14.44% |
| Accrued Expenses | $3.338B | $3.225B |
| YoY Change | 10.97% | 10.6% |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | $452.0M | $538.0M |
| YoY Change | 1.8% | 20.63% |
| Total Short-Term Liabilities | $4.369B | $4.405B |
| YoY Change | 10.13% | 12.29% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $21.21B | $21.54B |
| YoY Change | 5.47% | 6.58% |
| Other Long-Term Liabilities | $745.0M | $751.0M |
| YoY Change | 0.0% | 0.67% |
| Total Long-Term Liabilities | $21.95B | $22.29B |
| YoY Change | 5.28% | 6.37% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $4.369B | $4.405B |
| Total Long-Term Liabilities | $21.95B | $22.29B |
| Total Liabilities | $26.72B | $27.09B |
| YoY Change | 5.91% | 7.06% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | -$9.832B | -$9.842B |
| YoY Change | 5.03% | 4.85% |
| Common Stock | $10.66B | $10.64B |
| YoY Change | 0.6% | 0.64% |
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | -$1.175B | -$1.115B |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $26.50B | $26.91B |
| YoY Change | 3.89% | 5.77% |
Cashflow Statement
| Concept | 2024 Q2 | 2024 Q1 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | $10.00M | -$64.00M |
| YoY Change | -61.54% | -68.16% |
| Depreciation, Depletion And Amortization | $318.0M | $320.0M |
| YoY Change | 0.95% | 0.31% |
| Cash From Operating Activities | $380.0M | $211.0M |
| YoY Change | 84.47% | 37.01% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | $79.00M | $82.00M |
| YoY Change | 154.84% | 74.47% |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | $0.00 | $10.00M |
| YoY Change | -100.0% | -137.04% |
| Cash From Investing Activities | -$79.00M | -$73.00M |
| YoY Change | 163.33% | -6.41% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | ||
| YoY Change | ||
| Debt Paid & Issued, Net | $390.0M | |
| YoY Change | 39.78% | |
| Cash From Financing Activities | -424.0M | -$340.0M |
| YoY Change | 253.33% | 139.44% |
| NET CHANGE | ||
| Cash From Operating Activities | 380.0M | $211.0M |
| Cash From Investing Activities | -79.00M | -$73.00M |
| Cash From Financing Activities | -424.0M | -$340.0M |
| Net Change In Cash | -123.0M | -$207.0M |
| YoY Change | -319.64% | 245.0% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | $380.0M | $211.0M |
| Capital Expenditures | $79.00M | $82.00M |
| Free Cash Flow | $301.0M | $129.0M |
| YoY Change | 72.0% | 20.56% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2024Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
366674264 | shares |
| CY2024Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
366674264 | shares |
| CY2024Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
2153000000 | usd |
| CY2023Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
1944000000 | usd |
| CY2024Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
794000000 | usd |
| CY2023Q1 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
725000000 | usd |
| CY2024Q1 | us-gaap |
Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
151000000 | usd |
| CY2023Q1 | us-gaap |
Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
143000000 | usd |
| CY2024Q1 | bhc |
Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
|
274000000 | usd |
| CY2023Q1 | bhc |
Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
|
273000000 | usd |
| CY2024Q1 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
1000000 | usd |
| CY2023Q1 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
13000000 | usd |
| CY2024Q1 | bhc |
Restructuring Charges And Initial Public Offering Costs
RestructuringChargesAndInitialPublicOfferingCosts
|
12000000 | usd |
| CY2023Q1 | bhc |
Restructuring Charges And Initial Public Offering Costs
RestructuringChargesAndInitialPublicOfferingCosts
|
10000000 | usd |
| CY2024Q1 | us-gaap |
Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
|
0 | usd |
| CY2023Q1 | us-gaap |
Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
|
-23000000 | usd |
| CY2024Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
1872000000 | usd |
| CY2023Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
1769000000 | usd |
| CY2024Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
281000000 | usd |
| CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
175000000 | usd |
| CY2024Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
9000000 | usd |
| CY2023Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
6000000 | usd |
| CY2024Q1 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
355000000 | usd |
| CY2023Q1 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
307000000 | usd |
| CY2024Q1 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
11000000 | usd |
| CY2023Q1 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
0 | usd |
| CY2024Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-15000000 | usd |
| CY2023Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-10000000 | usd |
| CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-69000000 | usd |
| CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-136000000 | usd |
| CY2024Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
8000000 | usd |
| CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
73000000 | usd |
| CY2024Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-77000000 | usd |
| CY2023Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-209000000 | usd |
| CY2024Q1 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
-13000000 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
-8000000 | usd |
| CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-64000000 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-201000000 | usd |
| CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.17 | |
| CY2024Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.17 | |
| CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.55 | |
| CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.55 | |
| CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
366800000 | shares |
| CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
366800000 | shares |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
363300000 | shares |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
363300000 | shares |
| CY2024Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-77000000 | usd |
| CY2023Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-209000000 | usd |
| CY2024Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-34000000 | usd |
| CY2023Q1 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
65000000 | usd |
| CY2024Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-34000000 | usd |
| CY2023Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
65000000 | usd |
| CY2024Q1 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
-111000000 | usd |
| CY2023Q1 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
-144000000 | usd |
| CY2024Q1 | us-gaap |
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
-11000000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
63000000 | usd |
| CY2023Q1 | us-gaap |
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
-10000000 | usd |
| CY2024Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-100000000 | usd |
| CY2023Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-134000000 | usd |
| CY2023Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-82000000 | usd |
| CY2024Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
0 | usd |
| CY2024Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
33000000 | usd |
| CY2024Q1 | us-gaap |
Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
14000000 | usd |
| CY2024Q1 | us-gaap |
Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
|
0 | usd |
| CY2024Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-77000000 | usd |
| CY2024Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-34000000 | usd |
| CY2024Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-174000000 | usd |
| CY2022Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
260000000 | usd |
| CY2023Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
0 | usd |
| CY2023Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
41000000 | usd |
| CY2023Q1 | us-gaap |
Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
|
12000000 | usd |
| CY2023Q1 | us-gaap |
Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
|
0 | usd |
| CY2023Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-209000000 | usd |
| CY2023Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
65000000 | usd |
| CY2023Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
145000000 | usd |
| CY2024Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-77000000 | usd |
| CY2023Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-209000000 | usd |
| CY2024Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
320000000 | usd |
| CY2023Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
319000000 | usd |
| CY2024Q1 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
14000000 | usd |
| CY2023Q1 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
11000000 | usd |
| CY2024Q1 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
1000000 | usd |
| CY2023Q1 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
13000000 | usd |
| CY2024Q1 | bhc |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash
|
-2000000 | usd |
| CY2023Q1 | bhc |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset Cash
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAssetCash
|
31000000 | usd |
| CY2024Q1 | bhc |
Allowances For Losses On Accounts Receivable And Inventories
AllowancesForLossesOnAccountsReceivableAndInventories
|
15000000 | usd |
| CY2023Q1 | bhc |
Allowances For Losses On Accounts Receivable And Inventories
AllowancesForLossesOnAccountsReceivableAndInventories
|
10000000 | usd |
| CY2024Q1 | bhc |
Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
|
-57000000 | usd |
| CY2023Q1 | bhc |
Deferred Income Tax Noncash Expense Benefit
DeferredIncomeTaxNoncashExpenseBenefit
|
0 | usd |
| CY2024Q1 | us-gaap |
Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
|
4000000 | usd |
| CY2023Q1 | us-gaap |
Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
|
0 | usd |
| CY2024Q1 | bhc |
Gain Loss Related To Litigation Settlement Gross
GainLossRelatedToLitigationSettlementGross
|
-6000000 | usd |
| CY2023Q1 | bhc |
Gain Loss Related To Litigation Settlement Gross
GainLossRelatedToLitigationSettlementGross
|
-1000000 | usd |
| CY2024Q1 | us-gaap |
Payments For Legal Settlements
PaymentsForLegalSettlements
|
3000000 | usd |
| CY2023Q1 | us-gaap |
Payments For Legal Settlements
PaymentsForLegalSettlements
|
1000000 | usd |
| CY2024Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
33000000 | usd |
| CY2023Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
41000000 | usd |
| CY2024Q1 | bhc |
Derivative Gain Excluded Component
DerivativeGainExcludedComponent
|
3000000 | usd |
| CY2023Q1 | bhc |
Derivative Gain Excluded Component
DerivativeGainExcludedComponent
|
3000000 | usd |
| CY2024Q1 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
11000000 | usd |
| CY2023Q1 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
0 | usd |
| CY2024Q1 | bhc |
Payment For Debt Extinguishment Or Debt Prepayment Cost Operating Activities
PaymentForDebtExtinguishmentOrDebtPrepaymentCostOperatingActivities
|
0 | usd |
| CY2023Q1 | bhc |
Payment For Debt Extinguishment Or Debt Prepayment Cost Operating Activities
PaymentForDebtExtinguishmentOrDebtPrepaymentCostOperatingActivities
|
2000000 | usd |
| CY2024Q1 | bhc |
Payment For Contingent Consideration Liability Including Accretion Operating Activities
PaymentForContingentConsiderationLiabilityIncludingAccretionOperatingActivities
|
2000000 | usd |
| CY2023Q1 | bhc |
Payment For Contingent Consideration Liability Including Accretion Operating Activities
PaymentForContingentConsiderationLiabilityIncludingAccretionOperatingActivities
|
1000000 | usd |
| CY2024Q1 | bhc |
Amortization Interim Contract And Inventory Step From Acquisition
AmortizationInterimContractAndInventoryStepFromAcquisition
|
20000000 | usd |
| CY2023Q1 | bhc |
Amortization Interim Contract And Inventory Step From Acquisition
AmortizationInterimContractAndInventoryStepFromAcquisition
|
0 | usd |
| CY2024Q1 | bhc |
Foreign Currency Transaction And Other Gain Loss Before Tax
ForeignCurrencyTransactionAndOtherGainLossBeforeTax
|
4000000 | usd |
| CY2023Q1 | bhc |
Foreign Currency Transaction And Other Gain Loss Before Tax
ForeignCurrencyTransactionAndOtherGainLossBeforeTax
|
-5000000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-108000000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
144000000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
128000000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-121000000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
33000000 | usd |
| CY2024Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
51000000 | usd |
| CY2023Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-8000000 | usd |
| CY2024Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
211000000 | usd |
| CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
154000000 | usd |
| CY2024Q1 | bhc |
Payments To Acquire Businesses And For Other Investments
PaymentsToAcquireBusinessesAndForOtherInvestments
|
0 | usd |
| CY2023Q1 | bhc |
Payments To Acquire Businesses And For Other Investments
PaymentsToAcquireBusinessesAndForOtherInvestments
|
31000000 | usd |
| CY2024Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
82000000 | usd |
| CY2023Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
47000000 | usd |
| CY2024Q1 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
1000000 | usd |
| CY2023Q1 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
4000000 | usd |
| CY2024Q1 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
3000000 | usd |
| CY2023Q1 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
13000000 | usd |
| CY2024Q1 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
6000000 | usd |
| CY2023Q1 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
11000000 | usd |
| CY2024Q1 | us-gaap |
Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
|
1000000 | usd |
| CY2023Q1 | us-gaap |
Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
|
0 | usd |
| CY2024Q1 | bhc |
Interest Settlement On Cross Currency Swaps
InterestSettlementOnCrossCurrencySwaps
|
6000000 | usd |
| CY2023Q1 | bhc |
Interest Settlement On Cross Currency Swaps
InterestSettlementOnCrossCurrencySwaps
|
6000000 | usd |
| CY2024Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-73000000 | usd |
| CY2023Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-78000000 | usd |
| CY2024Q1 | us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
75000000 | usd |
| CY2023Q1 | us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
155000000 | usd |
| CY2024Q1 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
390000000 | usd |
| CY2023Q1 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
279000000 | usd |
| CY2024Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
14000000 | usd |
| CY2023Q1 | us-gaap |
Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
12000000 | usd |
| CY2024Q1 | us-gaap |
Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
|
7000000 | usd |
| CY2023Q1 | us-gaap |
Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
|
7000000 | usd |
| CY2024Q1 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
4000000 | usd |
| CY2023Q1 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
0 | usd |
| CY2024Q1 | us-gaap |
Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
|
0 | usd |
| CY2023Q1 | us-gaap |
Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
|
1000000 | usd |
| CY2024Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-340000000 | usd |
| CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-142000000 | usd |
| CY2024Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
-5000000 | usd |
| CY2023Q1 | us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
6000000 | usd |
| CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-207000000 | usd |
| CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-60000000 | usd |
| CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
962000000 | usd |
| CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
591000000 | usd |
| CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
755000000 | usd |
| CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
531000000 | usd |
| CY2024Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
733000000 | usd |
| CY2023Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
518000000 | usd |
| CY2024Q1 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
22000000 | usd |
| CY2023Q1 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
13000000 | usd |
| CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
755000000 | usd |
| CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
531000000 | usd |
| CY2024Q1 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">DESCRIPTION OF BUSINESS </span><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bausch Health Companies Inc. (the “Company” or “Bausch Health”) is a global, diversified specialty pharmaceutical and medical device company that develops, manufactures and markets, primarily in the therapeutic areas of gastroenterology (“GI”), hepatology, neurology and dermatology, a broad range of branded, generic and branded generic pharmaceuticals, over-the-counter (“OTC”) products and aesthetic medical devices, and, through its approximately 88% ownership of Bausch + Lomb Corporation (“Bausch + Lomb” or “B+L”), branded, and branded generic pharmaceuticals, OTC products and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment) in the therapeutic areas of eye health. The Company’s products are marketed directly or indirectly in approximately 90 countries.</span></div> | |
| CY2024Q1 | us-gaap |
Number Of Countries In Which Entity Operates
NumberOfCountriesInWhichEntityOperates
|
90 | country |
| CY2024Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In preparing the unaudited Condensed Consolidated Financial Statements, management is required to make estimates and assumptions. The estimates and assumptions used by the Company affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the unaudited Condensed Consolidated Financial Statements, and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from these estimates and the differences could be material. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On an ongoing basis, management reviews its estimates to ensure that these estimates appropriately reflect changes in the Company’s business and new information as it becomes available. If historical experience and other factors used by management to make these estimates do not reasonably reflect future activity, the Company’s results of operations and financial position could be materially impacted.</span></div> | |
| CY2023Q4 | us-gaap |
Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
|
1939000000 | usd |
| CY2024Q1 | us-gaap |
Valuation Allowances And Reserves Charged To Other Accounts
ValuationAllowancesAndReservesChargedToOtherAccounts
|
1694000000 | usd |
| CY2024Q1 | us-gaap |
Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
|
1589000000 | usd |
| CY2024Q1 | us-gaap |
Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
|
2044000000 | usd |
| CY2022Q4 | us-gaap |
Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
|
1910000000 | usd |
| CY2023Q1 | us-gaap |
Valuation Allowances And Reserves Charged To Other Accounts
ValuationAllowancesAndReservesChargedToOtherAccounts
|
1371000000 | usd |
| CY2023Q1 | us-gaap |
Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
|
1453000000 | usd |
| CY2023Q1 | us-gaap |
Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
|
1828000000 | usd |
| CY2023Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
34000000 | usd |
| CY2022Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
33000000 | usd |
| CY2024Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
0 | usd |
| CY2023Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
1000000 | usd |
| CY2024Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
0 | usd |
| CY2023Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
1000000 | usd |
| CY2024Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
|
0 | usd |
| CY2023Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
|
3000000 | usd |
| CY2024Q1 | bhc |
Accounts Receivable Allowance For Foreign Exchange And Other
AccountsReceivableAllowanceForForeignExchangeAndOther
|
0 | usd |
| CY2023Q1 | bhc |
Accounts Receivable Allowance For Foreign Exchange And Other
AccountsReceivableAllowanceForForeignExchangeAndOther
|
4000000 | usd |
| CY2024Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
34000000 | usd |
| CY2023Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
32000000 | usd |
| CY2024Q1 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
22000000 | usd |
| CY2024Q1 | bhc |
Highly Liquid Investments Maturity Period
HighlyLiquidInvestmentsMaturityPeriod
|
P3M | |
| CY2023Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
292000000 | usd |
| CY2022Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
241000000 | usd |
| CY2023Q1 | bhc |
Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List Not Disclosed Flag
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag
|
Acquisition-related contingent consideration | |
| CY2024Q1 | bhc |
Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List Not Disclosed Flag
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleListNotDisclosedFlag
|
Acquisition-related contingent consideration | |
| CY2024Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
|
-2000000 | usd |
| CY2023Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
|
31000000 | usd |
| CY2024Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
|
0 | usd |
| CY2023Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
|
5000000 | usd |
| CY2024Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
|
9000000 | usd |
| CY2023Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
|
8000000 | usd |
| CY2024Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
281000000 | usd |
| CY2023Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
269000000 | usd |
| CY2024Q1 | us-gaap |
Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
|
56000000 | usd |
| CY2023Q1 | us-gaap |
Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
|
50000000 | usd |
| CY2024Q1 | us-gaap |
Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
|
225000000 | usd |
| CY2023Q1 | us-gaap |
Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
|
219000000 | usd |
| CY2024Q1 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
548000000 | usd |
| CY2023Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
509000000 | usd |
| CY2024Q1 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
101000000 | usd |
| CY2023Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
124000000 | usd |
| CY2024Q1 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
987000000 | usd |
| CY2023Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
911000000 | usd |
| CY2024Q1 | us-gaap |
Inventory Gross
InventoryGross
|
1636000000 | usd |
| CY2023Q4 | us-gaap |
Inventory Gross
InventoryGross
|
1544000000 | usd |
| CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
27248000000 | usd |
| CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
22768000000 | usd |
| CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
4480000000 | usd |
| CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
27262000000 | usd |
| CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
22509000000 | usd |
| CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
4753000000 | usd |
| CY2024Q1 | us-gaap |
Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
|
28951000000 | usd |
| CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
22768000000 | usd |
| CY2024Q1 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
6183000000 | usd |
| CY2023Q4 | us-gaap |
Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
|
28965000000 | usd |
| CY2023Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
22509000000 | usd |
| CY2023Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
6456000000 | usd |
| CY2023Q1 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
13000000 | usd |
| CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
|
801000000 | usd |
| CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
994000000 | usd |
| CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
870000000 | usd |
| CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
831000000 | usd |
| CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
234000000 | usd |
| CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
|
216000000 | usd |
| CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
|
534000000 | usd |
| CY2024Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
4480000000 | usd |
| CY2022Q4 | us-gaap |
Goodwill
Goodwill
|
11547000000 | usd |
| CY2023 | us-gaap |
Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
|
31000000 | usd |
| CY2023 | us-gaap |
Goodwill Impairment Loss
GoodwillImpairmentLoss
|
493000000 | usd |
| CY2023 | us-gaap |
Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
|
-98000000 | usd |
| CY2023Q4 | us-gaap |
Goodwill
Goodwill
|
11183000000 | usd |
| CY2024Q1 | us-gaap |
Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
|
23000000 | usd |
| CY2024Q1 | us-gaap |
Goodwill
Goodwill
|
11160000000 | usd |
| CY2024Q1 | us-gaap |
Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
|
5497000000 | usd |
| CY2024Q1 | bhc |
Accrued Product Rebate Current
AccruedProductRebateCurrent
|
1167000000 | usd |
| CY2023Q4 | bhc |
Accrued Product Rebate Current
AccruedProductRebateCurrent
|
1069000000 | usd |
| CY2024Q1 | bhc |
Accrued Product Return Current
AccruedProductReturnCurrent
|
377000000 | usd |
| CY2023Q4 | bhc |
Accrued Product Return Current
AccruedProductReturnCurrent
|
380000000 | usd |
| CY2024Q1 | bhc |
Legalsettlementsandrelatedfees
Legalsettlementsandrelatedfees
|
347000000 | usd |
| CY2023Q4 | bhc |
Legalsettlementsandrelatedfees
Legalsettlementsandrelatedfees
|
344000000 | usd |
| CY2024Q1 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
276000000 | usd |
| CY2023Q4 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
360000000 | usd |
| CY2024Q1 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
266000000 | usd |
| CY2023Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
236000000 | usd |
| CY2024Q1 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
76000000 | usd |
| CY2023Q4 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
47000000 | usd |
| CY2024Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
716000000 | usd |
| CY2023Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
697000000 | usd |
| CY2024Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
3225000000 | usd |
| CY2023Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
3133000000 | usd |
| CY2024Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
8000000 | usd |
| CY2024Q1 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
20717000000 | usd |
| CY2024Q1 | us-gaap |
Long Term Debt
LongTermDebt
|
22074000000 | usd |
| CY2023Q4 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
21006000000 | usd |
| CY2023Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
22388000000 | usd |
| CY2024Q1 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
538000000 | usd |
| CY2023Q4 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
450000000 | usd |
| CY2024Q1 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
21536000000 | usd |
| CY2023Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
21938000000 | usd |
| CY2024Q1 | us-gaap |
Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
|
0.0802 | |
| CY2023Q4 | us-gaap |
Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
|
0.0805 | |
| CY2024Q1 | us-gaap |
Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
|
116000000 | usd |
| CY2024Q1 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
|
2675000000 | usd |
| CY2024Q1 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
|
757000000 | usd |
| CY2024Q1 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
|
6773000000 | usd |
| CY2024Q1 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
|
7194000000 | usd |
| CY2024Q1 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
|
1609000000 | usd |
| CY2024Q1 | us-gaap |
Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
|
1593000000 | usd |
| CY2024Q1 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
20717000000 | usd |
| CY2024Q1 | us-gaap |
Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
|
-1357000000 | usd |
| CY2024Q1 | us-gaap |
Long Term Debt
LongTermDebt
|
22074000000 | usd |
| CY2024Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
33000000 | usd |
| CY2023Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
41000000 | usd |
| CY2024Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
33000000 | usd |
| CY2023Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
41000000 | usd |
| CY2024Q1 | us-gaap |
Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
|
-6000000 | usd |
| CY2024Q1 | bhc |
Research And Development Expense Product Related
ResearchAndDevelopmentExpenseProductRelated
|
146000000 | usd |
| CY2023Q1 | bhc |
Research And Development Expense Product Related
ResearchAndDevelopmentExpenseProductRelated
|
136000000 | usd |
| CY2024Q1 | bhc |
Research And Development Expense Quality Assurance
ResearchAndDevelopmentExpenseQualityAssurance
|
5000000 | usd |
| CY2023Q1 | bhc |
Research And Development Expense Quality Assurance
ResearchAndDevelopmentExpenseQualityAssurance
|
7000000 | usd |
| CY2024Q1 | us-gaap |
Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
151000000 | usd |
| CY2023Q1 | us-gaap |
Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
143000000 | usd |
| CY2023Q1 | us-gaap |
Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
|
8000000 | usd |
| CY2024Q1 | us-gaap |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
-2000000 | usd |
| CY2023Q1 | us-gaap |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
31000000 | usd |
| CY2024Q1 | us-gaap |
Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
|
4000000 | usd |
| CY2023Q1 | us-gaap |
Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
|
0 | usd |
| CY2024Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
0 | usd |
| CY2023Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-23000000 | usd |
| CY2024Q1 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
28000000 | usd |
| CY2024Q1 | bhc |
Effective Income Tax Rate Reconciliation Discrete Items Amount
EffectiveIncomeTaxRateReconciliationDiscreteItemsAmount
|
-20000000 | usd |
| CY2024Q1 | us-gaap |
Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
|
-22000000 | usd |
| CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
73000000 | usd |
| CY2023Q1 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-13000000 | usd |
| CY2023Q1 | bhc |
Effective Income Tax Rate Reconciliation Discrete Items Amount
EffectiveIncomeTaxRateReconciliationDiscreteItemsAmount
|
86000000 | usd |
| CY2023Q1 | us-gaap |
Income Tax Reconciliation Tax Settlements
IncomeTaxReconciliationTaxSettlements
|
41000000 | usd |
| CY2023Q1 | us-gaap |
Income Tax Reconciliation Tax Contingencies
IncomeTaxReconciliationTaxContingencies
|
18000000 | usd |
| CY2023Q1 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
18000000 | usd |
| CY2023Q1 | us-gaap |
Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
|
6000000 | usd |
| CY2024Q1 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
2294000000 | usd |
| CY2023Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
2254000000 | usd |
| CY2024Q1 | bhc |
Unrecognized Tax Benefits Including Interest And Penalties
UnrecognizedTaxBenefitsIncludingInterestAndPenalties
|
880000000 | usd |
| CY2023Q4 | bhc |
Unrecognized Tax Benefits Including Interest And Penalties
UnrecognizedTaxBenefitsIncludingInterestAndPenalties
|
918000000 | usd |
| CY2024Q1 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
45000000 | usd |
| CY2023Q4 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
51000000 | usd |
| CY2024Q1 | us-gaap |
Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
|
408000000 | usd |
| CY2024Q1 | us-gaap |
Decrease In Unrecognized Tax Benefits Is Reasonably Possible
DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
|
30000000 | usd |
| CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-64000000 | usd |
| CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-201000000 | usd |
| CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
366800000 | shares |
| CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
366800000 | shares |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
363300000 | shares |
| CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
363300000 | shares |
| CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.17 | |
| CY2024Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.17 | |
| CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.55 | |
| CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.55 | |
| CY2024Q1 | bhc |
Legalsettlementsandrelatedfees
Legalsettlementsandrelatedfees
|
347000000 | usd |
| CY2024Q1 | bhc |
Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
|
274000000 | usd |
| CY2023Q1 | bhc |
Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold
AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold
|
273000000 | usd |
| CY2024Q1 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
1000000 | usd |
| CY2023Q1 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
13000000 | usd |
| CY2024Q1 | bhc |
Restructuring Charges And Initial Public Offering Costs
RestructuringChargesAndInitialPublicOfferingCosts
|
12000000 | usd |
| CY2023Q1 | bhc |
Restructuring Charges And Initial Public Offering Costs
RestructuringChargesAndInitialPublicOfferingCosts
|
10000000 | usd |
| CY2024Q1 | us-gaap |
Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
|
0 | usd |
| CY2023Q1 | us-gaap |
Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
|
-23000000 | usd |
| CY2024Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
281000000 | usd |
| CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
175000000 | usd |
| CY2024Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
9000000 | usd |
| CY2023Q1 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
6000000 | usd |
| CY2024Q1 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
355000000 | usd |
| CY2023Q1 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
307000000 | usd |
| CY2024Q1 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
11000000 | usd |
| CY2023Q1 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
0 | usd |
| CY2024Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-15000000 | usd |
| CY2023Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-10000000 | usd |
| CY2024Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-69000000 | usd |
| CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-136000000 | usd |
| CY2024Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
2153000000 | usd |
| CY2023Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
1944000000 | usd |
| CY2023Q1 | bhc |
Concentration Risk Number Of Products
ConcentrationRiskNumberOfProducts
|
10 | product |
| CY2024Q1 | bhc |
Concentration Risk Number Of Products
ConcentrationRiskNumberOfProducts
|
10 | product |
| CY2024Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
2153000000 | usd |
| CY2023Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
1944000000 | usd |
